Sitoe, N.; Ahmed, M.I.M.; Enosse, M.; Bakuli, A.; Chissumba, R.M.; Held, K.; Hoelscher, M.; Nhassengo, P.; Khosa, C.; Rachow, A.;
et al. Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection Status. Pathogens 2022, 11, 1034.
https://doi.org/10.3390/pathogens11091034
AMA Style
Sitoe N, Ahmed MIM, Enosse M, Bakuli A, Chissumba RM, Held K, Hoelscher M, Nhassengo P, Khosa C, Rachow A,
et al. Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection Status. Pathogens. 2022; 11(9):1034.
https://doi.org/10.3390/pathogens11091034
Chicago/Turabian Style
Sitoe, Nádia, Mohamed I. M. Ahmed, Maria Enosse, Abhishek Bakuli, Raquel Matavele Chissumba, Kathrin Held, Michael Hoelscher, Pedroso Nhassengo, Celso Khosa, Andrea Rachow,
and et al. 2022. "Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection Status" Pathogens 11, no. 9: 1034.
https://doi.org/10.3390/pathogens11091034
APA Style
Sitoe, N., Ahmed, M. I. M., Enosse, M., Bakuli, A., Chissumba, R. M., Held, K., Hoelscher, M., Nhassengo, P., Khosa, C., Rachow, A., Geldmacher, C., & on behalf of TB Sequel Consortium.
(2022). Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection Status. Pathogens, 11(9), 1034.
https://doi.org/10.3390/pathogens11091034
